The FreeStyle Libre 3 gets European thumbs up
The next generation of the FreeStyle Libre system has now been approved for use by people living with diabetes in Europe.
The FreeStyle Libre 3 technology provides continuous, real-time glucose readings automatically delivered to smartphones every minute.
With a 14-day wear time, the FreeStyle Libre 3 system includes the longest-lasting, self-applied CGM sensor available. The sensor is easy to apply with a one-piece applicator and is worn on the back of the upper arm, eliminating the need for painful fingersticks to view glucose levels.
People living with diabetes are at the centre of our design process, and we made our next-generation technology even more discreet for a better user experience to make managing diabetes as easy and seamless as possible Jared Watkin, senior vice president, Diabetes Care at Abbott
Jared Watkin, senior vice president, Diabetes Care at Abbott, said: “Abbott won’t stop innovating when there’s room to raise the bar. We’ve done that again with FreeStyle Libre 3, the smallest sensor that delivers life-changing benefits and best-in-class accuracy.
“People living with diabetes are at the centre of our design process, and we made our next-generation technology even more discreet for a better user experience to make managing diabetes as easy and seamless as possible.”
The system will be priced the same as previous generations of the device. In addition to the sensor, the system includes the FreeStyle Libre 3 mobile app, which is designed to enable users to capture and view their real-time glucose levels, glucose history and trend arrows showing how their glucose is changing with just a glance at their smartphone.
Mr Watkin added: “Since we launched the first disposable glucose sensor in 2014, we’ve always believed all people with diabetes should have access to high-quality, accurate and affordable diabetes technologies
“That’s why Abbott disrupted the traditional notion that CGMs have to sacrifice quality or accuracy for affordability, and we built our FreeStyle Libre family of products to deliver unparalleled results at a lower cost than any other CGM available.”
Abbott is launching the FreeStyle Libre 3 system in Europe in the coming months.